'Special K' could relieve depression

June 7, 2012
Professor Colleen Loo

(Medical Xpress) -- Recreational drug and anaesthetic, ketamine, is being trialled in people with severe depression and is providing almost instant relief from symptoms, offering fresh hope of a quick new way to manage the illness at its worst.

Ketamine, known colloquially as “Special K”, has been shown to alleviate in a matter of minutes or hours instead of the weeks it can take some conventional medications to treat the illness.

University of New South Wales researchers are leading the Australia-first clinical trial of to determine if it could be the next frontier in treating depression, which affects around 15 per cent of the population.

Professor Colleen Loo, from UNSW’s School of Psychiatry and the Black Dog Institute, says while traditional antidepressant drugs remain useful, ketamine is envisaged as an additional treatment option, not a replacement.

“The magnitude of improvement we’re seeing within 24 hours is just astounding compared to existing antidepressant treatments,” Professor Loo says.

“The only other antidepressant treatment that comes anything close to it is electro-convulsive therapy, or ECT, the most effective proven treatment for depression.”

Researchers are investigating the body’s response to ketamine by administering a range of small doses in the placebo-controlled trial, given by intravenous infusion under careful medical monitoring.

Ketamine works on a different part of the brain from other traditional antidepressants, which is helping researchers understand more about the brain and its role in depression.

“It’s a paradigm shift. All the other existing antidepressant medications work on receptor systems like serotonin, noradrenaline and dopamine, whereas this works on the glutamate system,” Professor Loo says.

A successful, ongoing trial could mean ketamine will be used in Australia in clinical settings within a decade.

Explore further: Ketamine helps see how the brain works in clinical depression

More information: Ketamine has so far been successfully trialled on a handful of people, with more participants being recruited. Anyone interested in participating in the trial should email n.katalinic@unsw.edu.au , contact 02 9113 1637 or visit the Black Dog Institute website for more information.
Candidates for the treatment are those adults with severe depression in need of medication but who haven’t responded to traditional treatments.

Related Stories

Ketamine helps see how the brain works in clinical depression

June 16, 2011
(Medical Xpress) -- In a new study published in Nature, Lisa Monteggia from the University of Texas Southwestern Medical Center looks at how the drug ketamine, typically used as an anesthetic or a popular recreational drug ...

Ketamine improved bipolar depression within minutes

May 30, 2012
Bipolar disorder is a serious and debilitating condition where individuals experience severe swings in mood between mania and depression. The episodes of low or elevated mood can last days or months, and the risk of suicide ...

Drug boosts growth factor to jump-start rapid antidepressant response

June 22, 2011
(Medical Xpress) -- A study in mice has pinpointed a pivotal new player in triggering the rapid antidepressant response produced by ketamine. By deactivating a little-known enzyme, the drug takes the brakes off rapid synthesis ...

Recommended for you

Scientists researching drugs that could improve brain function in people with schizophrenia

October 12, 2017
Virginia Commonwealth University researchers are testing if drugs known as HDAC inhibitors improve cognition in patients with schizophrenia who have been treated with the antipsychotic drug clozapine.

Researchers find a fine timeline between delusion and reality

October 12, 2017
The line between reality and delusion may be just a matter of time, a new Yale study suggests.

Virtual humans work better than current ways to identify post-traumatic stress in soldiers

October 12, 2017
Soldiers are more likely to open up about post-traumatic stress when interviewed by a virtual interviewer than by taking a survey, finds a study published today in open-access journal Frontiers in Robotics and AI. A computer-generated ...

Women seen as younger when eyes, lips and eyebrows stand out

October 11, 2017
Aspects of facial contrast, a measure of how much facial features stand out in the face, decrease with age in women across a variety of ethnic groups, finds a study in open access journal Frontiers in Psychology. The study ...

Voice-only communication more accurate than visual cues for identifying others' feelings, study says

October 10, 2017
If you want to know how someone is feeling, it might be better to close your eyes and use your ears: People tend to read others' emotions more accurately when they listen and don't look, according to research published by ...

Experts call for more rigor, less hype, for mindfulness and meditation

October 10, 2017
Dependable scientific evidence has lagged worrisomely behind the rapid and widespread adoption of mindfulness and meditation for pursuing an array of mental and physical wellness goals, wrote a group of 15 experts in a new ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Eventide
1 / 5 (1) Jun 08, 2012
Ecstasy deserves a shot at depression treatments trials too.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.